Literature DB >> 19615727

Epidemiologic correlates of ovarian cortical inclusion cysts (CICs) support a dual precursor pathway to pelvic epithelial cancer.

Ann K Folkins1, Aasia Saleemuddin1, Leslie A Garrett2, Judy E Garber3, Michael G Muto2, Shelley S Tworoger4, Christopher P Crum5.   

Abstract

OBJECTIVE: Many ovarian carcinomas are presumed to arise within ovarian cortical inclusion cysts (CICs). This study examined the frequency of ovarian CICs in relation to epidemiologic risk factors in women with BRCA1 and BRCA2 (BRCA+) mutations.
METHODS: BRCA+ women who underwent risk-reducing bilateral salpingo-oophorectomy were studied (n=74). Fifteen demographic variables (e.g., age at time of surgery, age at first birth, age at menopause, body mass index (BMI), gravidity) from a review of the medical records and three pathologic variables (cystic and atretic follicles, corpora lutea) were recorded. Statistical associations were made using T-test or Chi Square analysis and logistic regression analysis for p-trend.
RESULTS: Women whose ovaries contained 7 for more CICs were older at first birth (p=0.034), surgery (p=0.059), menopause (p=0.046) and had a higher BMI (p=0.034) than those with <7 CICs. Regression analysis revealed a significant association between CICs and increasing BMI (p=0.01).
CONCLUSIONS: CICs correlate with greater body mass index, similar to low-grade serous and endometrioid tumors and in contrast to high-grade serous carcinoma and its putative precursor in the fallopian tube. A model is presented for ovarian and tubal pathways to pelvic cancer that are linked to different microscopic precursors with distinct epidemiologic correlates.

Entities:  

Mesh:

Year:  2009        PMID: 19615727      PMCID: PMC2739135          DOI: 10.1016/j.ygyno.2009.06.032

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  31 in total

1.  Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes.

Authors:  R R Barakat; M G Federici; P E Saigo; M E Robson; K Offit; J Boyd
Journal:  Cancer       Date:  2000-07-15       Impact factor: 6.860

2.  Timing of pregnancy and the risk of epithelial ovarian cancer.

Authors:  David C Whiteman; Victor Siskind; David M Purdie; Adèle C Green
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-01       Impact factor: 4.254

3.  Lack of proliferative activity of surface epithelial inclusion cysts of the ovary.

Authors:  D S Heller; M Hameed; R Baergen
Journal:  Int J Gynecol Cancer       Date:  2003 May-Jun       Impact factor: 3.437

4.  Incessant ovulation--a factor in ovarian neoplasia?

Authors:  M F Fathalla
Journal:  Lancet       Date:  1971-07-17       Impact factor: 79.321

5.  Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study.

Authors:  T Riman; P W Dickman; S Nilsson; N Correia; H Nordlinder; C M Magnusson; I R Persson
Journal:  Gynecol Oncol       Date:  2001-12       Impact factor: 5.482

6.  Diverse tumorigenic pathways in ovarian serous carcinoma.

Authors:  Gad Singer; Robert J Kurman; Hsueh-Wei Chang; Sarah K R Cho; Ie-Ming Shih
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

Review 7.  Prevention of ovarian cancer: intraepithelial neoplasia.

Authors:  Molly A Brewer; Karen Johnson; Michele Follen; David Gershenson; Robert Bast
Journal:  Clin Cancer Res       Date:  2003-01       Impact factor: 12.531

8.  Body mass index and risk of ovarian cancer.

Authors:  Michael F Leitzmann; Corinna Koebnick; Kim N Danforth; Louise A Brinton; Steven C Moore; Albert R Hollenbeck; Arthur Schatzkin; James V Lacey
Journal:  Cancer       Date:  2009-02-15       Impact factor: 6.860

9.  Height, body mass index, and ovarian cancer: a follow-up of 1.1 million Norwegian women.

Authors:  Anders Engeland; Steinar Tretli; Tone Bjørge
Journal:  J Natl Cancer Inst       Date:  2003-08-20       Impact factor: 13.506

10.  Ovarian cystomas and ovulation, a histogenetic concept.

Authors:  J Zajicek
Journal:  Tumori       Date:  1977 Sep-Oct
View more
  10 in total

1.  Ovarian surface epitheliectomy in the non-human primate: continued cyclic ovarian function and limited epithelial replacement.

Authors:  Jay W Wright; Tanja Pejovic; Leigh Jurevic; Cecily V Bishop; Theodore Hobbs; Richard L Stouffer
Journal:  Hum Reprod       Date:  2011-03-18       Impact factor: 6.918

2.  Dynamics of the primate ovarian surface epithelium during the ovulatory menstrual cycle.

Authors:  Jay W Wright; Leigh Jurevic; Richard L Stouffer
Journal:  Hum Reprod       Date:  2011-03-18       Impact factor: 6.918

3.  Ovarian Cancer Is an Imported Disease: Fact or Fiction?

Authors:  Elisabetta Kuhn; Robert J Kurman; Ie-Ming Shih
Journal:  Curr Obstet Gynecol Rep       Date:  2012-03

4.  Precursor lesions of high-grade serous ovarian carcinoma: morphological and molecular characteristics.

Authors:  Amy L Gross; Robert J Kurman; Russell Vang; Ie-Ming Shih; Kala Visvanathan
Journal:  J Oncol       Date:  2010-04-27       Impact factor: 4.375

5.  Low-Stage High-Grade Serous Ovarian Carcinomas: Support for an Extraovarian Origin.

Authors:  Elizabeth Morency; Mario M Leitao; Robert A Soslow
Journal:  Int J Gynecol Pathol       Date:  2016-05       Impact factor: 2.762

6.  Epithelial ovarian carcinoma types and the coexistence of ovarian tumor conditions.

Authors:  Catharina C van Niekerk; Johan Bulten; José A A M van Dijck; André L M Verbeek
Journal:  ISRN Obstet Gynecol       Date:  2011-07-14

Review 7.  Exploring the Role of Fallopian Ciliated Cells in the Pathogenesis of High-Grade Serous Ovarian Cancer.

Authors:  Michela Coan; Gian Luca Rampioni Vinciguerra; Laura Cesaratto; Emanuela Gardenal; Riccardo Bianchet; Erik Dassi; Andrea Vecchione; Gustavo Baldassarre; Riccardo Spizzo; Milena Sabrina Nicoloso
Journal:  Int J Mol Sci       Date:  2018-08-24       Impact factor: 5.923

8.  Oncolytic virus immunotherapies in ovarian cancer: moving beyond adenoviruses.

Authors:  Joseph Hoare; Nicola Campbell; Elisabete Carapuça
Journal:  Porto Biomed J       Date:  2018-06-29

Review 9.  Low-Grade Serous Carcinoma of the Ovary: The Current Status.

Authors:  Abdulaziz Babaier; Hanan Mal; Waleed Alselwi; Prafull Ghatage
Journal:  Diagnostics (Basel)       Date:  2022-02-10

Review 10.  Ovarian Cancer, Cancer Stem Cells and Current Treatment Strategies: A Potential Role of Magmas in the Current Treatment Methods.

Authors:  Nuzhat Ahmed; Elif Kadife; Ali Raza; Mary Short; Paul T Jubinsky; George Kannourakis
Journal:  Cells       Date:  2020-03-14       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.